The Impact of Genetic Polymorphism in CYP3A5 on the Pharmacokinetics of the Mixed 3A4/5 Substrates Midazolam and Tacrolimus Assessed by Clinical Trial Simulation (CTS)

Author(s): H. F. Perrett, Z. E. Barter, M. S. Lennard, G. T. Tucker, A. Rostami-Hodjegan
Year:

Learn More LinkedIn Twitter Facebook Email